UVB-induced 1,25(OH)2D3 production and vitamin D activity in intestinal CaCo-2 cells and in THP-1 macrophages pretreated with a sterol Δ7-reductase inhibitor

Journal of Cellular Biochemistry

Volumn 99, Issue 1, 2006, Pages 229-240

  Vantieghem, Katleen ^a   Overbergh, Lut ^a   Carmeliet, Geert ^a   De Haes, Petra ^b   Bouillon, Roger ^a,c   Segaert, Siegfried ^a,b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c LEGENDO   (Belgium)

Author keywords

CaCo 2 cells; THP 1 cells; Ultraviolet; Vitamin D system

Indexed keywords

4 [2 [1 (4 CHLOROCINNAMYL) 4 PIPERAZINYL]ETHYL]BENZOIC ACID; 7 DEHYDROCHOLESTEROL; CALCITRIOL; CYTOCHROME P450; CYTOCHROME P450 24; CYTOCHROME P450 27A1; CYTOCHROME P450 27B1; CYTOCHROME P450 2R1; DELTA7 REDUCTASE INHIBITOR; ENZYME INHIBITOR; MESSENGER RNA; OXYGENASE; STEROID REDUCTASE; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D BINDING PROTEIN; VITAMIN D RECEPTOR;

ARTICLE; AUTOCRINE EFFECT; CELL SPECIFICITY; CELL STRAIN CACO 2; CELL STRAIN THP 1; CELL TYPE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; EPIDERMIS CELL; GENETIC TRANSFECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; KERATINOCYTE; MACROPHAGE; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN BINDING; RADIOIMMUNOASSAY; ULTRAVIOLET B RADIATION;

CACO-2 CELLS; CELL LINE; CELL SURVIVAL; CHOLECALCIFEROL; DEHYDROCHOLESTEROLS; DOSE-RESPONSE RELATIONSHIP, RADIATION; ENZYME INHIBITORS; HUMANS; INTESTINES; MACROPHAGES; OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS; PIPERAZINES; STEROID HYDROXYLASES; ULTRAVIOLET RAYS; VITAMIN D; VITAMIN D-BINDING PROTEIN;

EID: 33748075121     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.20910     Document Type: Article

References (60)

1. Adachi M, Gazel A, Pintucci G, Shuck A, Shifteh S, Ginsburg D, Rao LS, Kaneko T, Freedberg IM, Tamaki K, Blumenberg M. 2003. Specificity in stress response: Epidermal keratinocytes exhibit specialized UV-responsive signal transduction pathways. DNA Cell Biol 22:665-677.
2. Andersson S, Davis DL, Dahlback H, Jornvall H, Russell DW. 1989. Cloning, structure, and expression of the mitochondrial cytochrome P-450 sterol 26-hydroxylase, a bile acid biosynthetic enzyme. J Biol Chem 264:8222-8229.
3. Aw TY. 1999. Molecular and cellular responses to oxidative stress and changes in oxidation-reduction imbalance in the intestine. Am J Clin Nutr 70:557-565.
4. Bareis P, Bises G, Bischof MG, Cross HS, Peterlik M. 2001. 25-hydroxy-vitamin d metabolism in human colon cancer cells during tumor progression. Biochem Biophys Res Commun 285:1012-1017.
5. Bareis P, Kallay E, Bischof MG, Bises G, Hofer H, Potzi C, Manhardt T, Bland R, Cross HS. 2002. Clonal differences in expression of 25-hydroxyvitamin D(3)-1alpha-hydroxylase, of 25-hydroxyvitamin D(3)-24-hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: Effects of epidermal growth factor and 1alpha,25-dihydroxyvitamin D(3). Exp Cell Res 276:320-327.
6. Bikle DD, Pillai S. 1993. Vitamin D, calcium, and epidermal differentiation. Endocr Rev 14:3-19.
7. Bikle DD, Nemanic MK, Gee E, Elias P. 1986a. 1,25-Dihydroxyvitamin D3 production by human keratinocytes. Kinetics and regulation. J Clin Invest 78:557-566.
8. Bikle DD, Nemanic MK, Whitney JO, Elias PW. 1986b. Neonatal human foreskin keratinocytes produce 1,25-dihydroxyvitamin D3. Biochemistry 25:1545-1548.
9. Bikle DD, Chang S, Crumrine D, Elalieh H, Man MQ, Choi EH, Dardenne O, Xie Z, Arnaud RS, Feingold K, Elias PM. 2004. 25 Hydroxyvitamin D 1 alpha-hydroxylase is required for optimal epidermal differentiation and permeability barrier homeostasis. J Invest Dermatol 122:984-992.
10. Bischof MG, Siu-Caldera ML, Weiskopf A, Vouros P, Cross HS, Peterlik M, Reddy GS. 1998. Differentiation-related pathways of 1 alpha,25- dihydroxycholecalciferol metabolism in human colon adenocarcinoma-derived Caco-2 cells: Production of 1 alpha,25-dihydroxy-3epi-cholecalciferol. Exp Cell Res 241:194-201.
11. Blunt JW, DeLuca HF, Schnoes HK. 1968. 25-hydroxycholecalciferol: A biologically active metabolite of vitamin D3. Biochemistry 7:3317-3322.
12. Bouillon R, De Moor P, Baggiolini EG, Uskokovic MR. 1980a. A radioimmunoassay for 1,25-dihydroxycholecalciferol. Clin Chem 26:562-567.
13. Bouillon R, Van Baelen H, De Moor P. 1980b. Comparative study of the affinity of the serum vitamin D-binding protein. J Steroid Biochem 13:1029-1034.
14. Bouillon R, Okamura WH, Norman AW. 1995. Structure-function relationships in the vitamin D endocrine system. Endocr Rev 16:200-257.
15. Cejkova J, Stipek S, Crkovska J, Ardan T, Platenik J, Cejka C, Midelfart A. 2004. UV Rays, the prooxidant/antioxidant imbalance in the cornea and oxidative eye damage. Physiol Res 53:1-10.
16. Chen KS, Prahl JM, DeLuca HF. 1993. Isolation and expression of human 1,25-dihydroxyvitamin D3 24-hydroxylase cDNA. Proc Natl Acad Sci USA 90:4543-4547.
17. Chen ML, Heinrich G, Ohyama YI, Okuda K, Omdahl JL, Chen TC, Holick MF. 1994. Expression of 25-hydroxyvitamin D3-24-hydroxylase mRNA in cultured human keratinocytes. Proc Soc Exp Biol Med 207:57-61.
18. Cheng JB, Motola DL, Mangelsdorf DJ, Russell DW. 2003. De-orphanization of cytochrome P450 2R1: A microsomal vitamin D 25-hydroxylase. J Biol Chem 278:38084-38093.
19. Cheng JB, Levine MA, Bell NH, Mangelsdorf DJ, Russell DW. 2004. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc Natl Acad Sci USA 101:7711-7715.
20. Cross HS, Peterlik M, Reddy GS, Schuster I. 1997. Vitamin D metabolism in human colon adenocarcinoma-derived Caco-2 cells: Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase activity and regulation of side-chain metabolism. J Steroid Biochem Mol Biol 62:21-28.
21. De Haes P, Garmyn M, Degreef H, Vantieghem K, Bouillon R, Segaert S. 2003. 1,25-Dihydroxyvitamin D3 inhibits ultraviolet B-induced apoptosis, Jun kinase activation, and interleukin-6 production in primary human keratinocytes. J Cell Biochem 89:663-673.
22. Delvin EE, Arabian A, Glorieux FH, Mamer OA. 1985. In vitro metabolism of 25-hydroxycholecalciferol by isolated cells from human decidua. J Clin Endocrinol Metab 60:880-885.
23. Dusso AS, Kamimura S, Gallieni M, Zhong M, Negrea L, Shapiro S, Slatopolsky E. 1997. Gamma-Interferon-induced resistance to 1,25-(OH)2 D3 in human monocytes and macrophages: A mechanism for the hypercalcemia of various granulomatoses. J Clin Endocrinol Metab 82:2222-2232.
24. Friedrich M, Villena-Heinsen C, Axt-Fliedner R, Meyberg R, Tilgen W, Schmidt W, Reichrath J. 2002. Analysis of 25-hydroxyvitamin D3-1alpha- hydroxylase in cervical tissue. Anticancer Res 22:183-186.
25. Fu GK, Lin D, Zhang MY, Bikle DD, Shackleton CH, Miller WL, Portale AA. 1997. Cloning of human 25-hydroxyvitamin D-1 alpha-hydroxylase and mutations causing vitamin D-dependent rickets type 1. Mol Endocrinol 11:1961-1970.
26. Hansson M, Ellis E, Hunt MC, Schmitz G, Babiker A. 2003. Marked induction of sterol 27-hydroxylase activity and mRNA levels during differentiation of human cultured monocytes into macrophages. Biochim Biophys Acta 1593:283-289.
27. Hewison M, Zehnder D, Chakraverty R, Adams JS. 2004. Vitamin D and barrier function: A novel role for extrarenal 1 alpha-hydroxylase. Mol Cell Endocrinol 215:31-38.
28. Holick MF. 1988. Skin: Site of the synthesis of vitamin D and a target tissue for the active form, 1,25-dihydroxyvitamin D3. Ann NY Acad Sci 548:14-26.
29. Howard GA, Turner RT, Sherrard DJ, Baylink DJ. 1981. Human bone cells in culture metabolize 25-hydroxyvitamin D3 to 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3. J Biol Chem 256:7738-7740.
30. Ichikawa F, Sato K, Nanjo M, Nishii Y, Shinki T, Takahashi N, Suda T. 1995. Mouse primary osteoblasts express vitamin D3 25-hydroxylase mRNA and convert 1 alpha-hydroxyvitamin D3 into 1 alpha,25-dihydroxyvitamin D3. Bone 16:129-135.
31. Kitano Y, Okada N. 1983. Separation of the epidermal sheet by dispase. Br J Dermatol 108:555-560.
32. Lawson DE, Fraser DR, Kodicek E, Morris HR, Williams DH. 1971. Identification of 1,25-dihydroxycholecalciferol, a new kidney hormone controlling calcium metabolism. Nature 230:228-230.
33. Lehmann B, Tiebel O, Meurer M. 1999. Expression of vitamin D3 25-hydroxylase (CYP27) mRNA after induction by vitamin D3 or UVB radiation in keratinocytes of human skin equivalents-a preliminary study. Arch Dermatol Res 291:507-510.
34. Lehmann B, Knuschke P, Meurer M. 2000. UVB-induced conversion of 7-dehydrocholesterol to 1 alpha,25-dihydroxyvitamin D3 (calcitriol) in the human keratinocyte line HaCaT. Photochem Photobiol 72:803-809.
35. Lehmann B, Genehr T, Knuschke P, Pietzsch J, Meurer M. 2001. UVB-induced conversion of 7-dehydrocholesterol to 1alpha,25-dihydroxyvitamin D3 in an in vitro human skin equivalent model. J Invest Dermatol 117:1179-1185.
36. Lehmann B, Sauter W, Knuschke P, Dressler S, Meurer M. 2003. Demonstration of UVB-induced synthesis of 1 alpha,25-dihydroxyvitamin D3 (calcitriol) in human skin by microdialysis. Arch Dermatol Res 295:24-28.
37. Makin G, Lohnes D, Byford V, Ray R, Jones G. 1989. Target cell metabolism of 1,25-dihydroxyvitamin D3 to calcitroic acid. Evidence for a pathway in kidney and bone involving 24-oxidation. Biochem J 262:173-180.
38. Monkawa T, Yoshida T, Hayashi M, Saruta T. 2000. Identification of 25-hydroxyvitamin D3 1 alpha-hydroxylase gene expression in macrophages. Kidney Int 58:559-568.
39. Nemanic MK, Whitney J, Elias PM. 1985. In vitro synthesis of vitamin D-3 by cultured human keratinocytes and fibroblasts: Action spectrum and effect of AY-9944. Biochim Biophys Acta 841:267-277.
40. Norman AW. 1998. Sunlight, season, skin pigmentation, vitamin D, and 25-hydroxyvitamin D: Integral components of the vitamin D endocrine system. Am J Clin Nutr 67:1108-1110.
41. Nykjaer A, Fyfe JC, Kozyraki R, Leheste JR, Jacobsen C, Nielsen MS, Verroust PJ, Aminoff M, de la CA, Moestrup SK, Ray R, Gliemann J, Willnow TE, Christensen EI. 2001. Cubilin dysfunction causes abnormal metabolism of the steroid hormone 25(OH) vitamin D(3). Proc Natl Acad Sci USA 98:13895-13900.
42. Otto AI, Riou L, Marionnet C, Mori T, Sarasin A, Magnaldo T. 1999. Differential behaviors toward ultraviolet A and B radiation of fibroblasts and keratinocytes from normal and DNA-repair-deficient patients. Cancer Res 59:1212-1218.
43. Overbergh L, Stoffels K, Valckx D, Giulietti A, Bouillon R, Mathieu C. 2004. Regulation of 25-hydroxyvitamin d-1alpha-hydroxylase by IFNgamma in human monocytic THP1 cells. J Steroid Biochem Mol Biol 89-90:453-455.
44. Quack M, Szafranski K, Rouvinen J, Carlberg C. 1998. The role of the T-box for the function of the vitamin D receptor on different types of response elements. Nucleic Acids Res 26:5372-5378.
45. Ramanujam KS, Seetharam S, Ramasamy M, Seetharam B. 1991. Expression of cobalamin transport proteins and cobalamin transcytosis by colon adenocarcinoma cells. Am J Physiol 260:G416-G422.
46. Sanders LM, Henderson CE, Hong MY, Barhoumi R, Burghardt RC, Carroll RJ, Turner ND, Chapkin RS, Lupton JR. 2004. Pro-oxidant environment of the colon compared to the small intestine may contribute to greater cancer susceptibility. Cancer Lett 208:155-161.
47. Schoenmakers E, Verrijdt G, Peeters B, Verhoeven G, Rombauts W, Claessens F. 2000. Differences in DNA binding characteristics of the androgen and glucocorticoid receptors can determine hormone-specific responses. J Biol Chem 275:12290-12297.
48. Schuessler M, Astecker N, Herzig G, Vorisek G, Schuster I. 2001. Skin is an autonomous organ in synthesis, two-step activation and degradation of vitamin D(3): CYP27 in epidermis completes the set of essential vitamin D(3)-hydroxylases. Steroids 66:399-408.
49. Schwartz GG, Whitlatch LW, Chen TC, Lokeshwar BL, Holick MF. 1998. Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3. Cancer Epidemiol Biomarkers Prev 7:391-395.
50. Segaert S, Garmyn M, Degreef H, Bouillon R. 1997. Retinoic acid modulates the anti-proliferative effect of 1,25-dihydroxyvitamin D3 in cultured human epidermal keratinocytes. J Invest Dermatol 109:46-54.
51. Segersten U, Correa P, Hewison M, Hellman P, Dralle H, Carling T, Akerstrom G, Westin G. 2002. 25-hydroxyvitamin D(3)-1alpha-hydroxylase expression in normal and pathological parathyroid glands. J Clin Endocrinol Metab 87:2967-2972.
52. Shefer S, Salen G, Batta AK, Honda A, Tint GS, Irons M, Elias ER, Chen TC, Holick MF. 1995. Markedly inhibited 7-dehydrocholesterol-delta 7-reductase activity in liver microsomes from Smith-Lemli-Opitz homozygotes. J Clin Invest 96:1779-1785.
53. Shefer S, Salen G, Honda A, Batta AK, Nguyen LB, Tint GS, Ioannou YA, Desnick R. 1998. Regulation of rat hepatic 3beta-hydroxysterol delta7-reductase: Substrate specificity, competitive and non-competitive inhibition, and phosphorylation/dephosphorylation. J Lipid Res 39:2471-2476.
54. Theodoropoulos C, Demers C, Mirshahi A, Gascon-Barre M. 2001. 1,25-Dihydroxyvitamin D(3) downregulates the rat intestinal vitamin D(3)-25-hydroxylase CYP27A. Am J Physiol Endocrinol Metab 281:E315-E325.
55. Tomon M, Tenenhouse HS, Jones G. 1990. Expression of 25-hydroxyvitamin D3-24-hydroxylase activity in Caco-2 cells. An in vitro model of intestinal vitamin D catabolism. Endocrinology 126:2868-2875.
56. Usui E, Noshiro M, Okuda K. 1990. Molecular cloning of cDNA for vitamin D3 25-hydroxylase from rat liver mitochondria. FEBS Lett 262:135-138.
57. Van Baelen H, Bouillon R, De Moor P. 1980. Vitamin D-binding protein (Gc-globulin) binds actin. J Biol Chem 255:2270-2272.
58. Vantieghem K, Kissmeyer AM, Haes PD, Bouillon R, Segaert S. 2005. UVB-induced production of 1,25-dihydroxyvitamin D(3) and vitamin D activity in human keratinocytes pretreated with a sterol Delta(7)-reductase inhibitor. J Cell Biochem epub ahead of print (2005 Dec 13).
59. Xu D, Fyfe JC. 2000. Cubilin expression and posttranslational modification in the canine gastrointestinal tract. Am J Physiol Gastrointest Liver Physiol 279:G748-G756.
60. Zehnder D, Bland R, Williams MC, McNinch RW, Howie AJ, Stewart PM, Hewison M. 2001. Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab 86:888-894.